"Community Cancer Trials of Utah, LLC is an independent, community practice-based research organization intended to provide cancer patients with access to high-quality clinical trials in their own community, away from the stresses, inconveniences and high cost of an academic medical center or hospital-based system. Community Cancer Trials of Utah (CCTU) is affiliated with Utah Hematology Oncology, PC and CCTU's activities are conducted in cooperation with UHO's providers, staff, and facilities."

During the past decade, Community Cancer Trials of Utah conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 3 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Community Cancer Trials of Utah" #1 sponsor was "Exact Sciences Corporation" with 3 trials, followed by "Celgene" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Aadi Bioscience, Inc." with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Community Cancer Trials of Utah" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Amalgam Rx" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Community Cancer Trials of Utah" are "Breast Cancer" (3 trials), "Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Esophageal Cancer" (2 trials) and "Metastatic Cancer" (2 trials). Many other conditions were trialed in "Community Cancer Trials of Utah" in a lesser frequency.

Most popular intervention types in "Community Cancer Trials of Utah" are "Drug" (12 trials), "Other" (3 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bendamustine" (2 trials), "Blood Sample Collection" (2 trials), "Cyclophosphamide" (2 trials), "Docetaxel" (2 trials) and "Rituximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Community Cancer Trials of Utah" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Community Cancer Trials of Utah". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Community Cancer Trials of Utah, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Community Cancer Trials of Utah, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".